The validity and reliability of the Thai version of the asthma control test.

IF 2.3 4区 医学 Q3 ALLERGY Asian Pacific journal of allergy and immunology Pub Date : 2024-03-01 DOI:10.12932/AP-130820-0940
Nutchanok Niyatiwatchanchai, Warawut Chaiwong, Chaicharn Pothirat
{"title":"The validity and reliability of the Thai version of the asthma control test.","authors":"Nutchanok Niyatiwatchanchai, Warawut Chaiwong, Chaicharn Pothirat","doi":"10.12932/AP-130820-0940","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Asthma Control Test (ACT) has been widely used for the assessment of asthma control. However, it has never been validated in adult Thai asthmatic patients.</p><p><strong>Objective: </strong>To determine the validity and reliability of the Thai version of the ACT in adult Thai asthmatic patients.</p><p><strong>Methods: </strong>Any correlation between ACT and level of asthma controlled was determined using the Spearman's rank correlation coefficient. The ACT was carried out at 2 visits to a physician (4-12 weeks apart) to ascertain the level of reliability. Discriminant validity was determined using an area under receiver operating characteristic curve (AuROC) to identify the optimum cut-off point of the levels of control.</p><p><strong>Results: </strong>Seventy-one asthmatic adult patients, 40 (56.3%) female with a mean age of 54.2 ± 14.7 years were enrolled. The Thai version of ACT showed an acceptable internal consistency reliability with a Cronbach's alpha = 0.75. Test-retest reliability was 0.82. There was a significant correlation between the ACT scores and GINA symptom control tool (r = 0.87, p < 0.001). An ACT ≤ 22 was used to screen \"not well-controlled\" asthma with a sensitivity of 96.4% and specificity of 93.0% and an ACT score ≤ 19 was used to screen \"uncontrolled\" asthma.</p><p><strong>Conclusions: </strong>The Thai version of ACT is valid and a reliable tool for use in adult Thai asthmatic patients. However, the cut off points of ACT for levels of control should be changed to 22 and 19 for differentiation between well vs. partly controlled and partly vs. uncontrolled asthma, respectively.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"24-29"},"PeriodicalIF":2.3000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific journal of allergy and immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12932/AP-130820-0940","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Asthma Control Test (ACT) has been widely used for the assessment of asthma control. However, it has never been validated in adult Thai asthmatic patients.

Objective: To determine the validity and reliability of the Thai version of the ACT in adult Thai asthmatic patients.

Methods: Any correlation between ACT and level of asthma controlled was determined using the Spearman's rank correlation coefficient. The ACT was carried out at 2 visits to a physician (4-12 weeks apart) to ascertain the level of reliability. Discriminant validity was determined using an area under receiver operating characteristic curve (AuROC) to identify the optimum cut-off point of the levels of control.

Results: Seventy-one asthmatic adult patients, 40 (56.3%) female with a mean age of 54.2 ± 14.7 years were enrolled. The Thai version of ACT showed an acceptable internal consistency reliability with a Cronbach's alpha = 0.75. Test-retest reliability was 0.82. There was a significant correlation between the ACT scores and GINA symptom control tool (r = 0.87, p < 0.001). An ACT ≤ 22 was used to screen "not well-controlled" asthma with a sensitivity of 96.4% and specificity of 93.0% and an ACT score ≤ 19 was used to screen "uncontrolled" asthma.

Conclusions: The Thai version of ACT is valid and a reliable tool for use in adult Thai asthmatic patients. However, the cut off points of ACT for levels of control should be changed to 22 and 19 for differentiation between well vs. partly controlled and partly vs. uncontrolled asthma, respectively.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
泰语版哮喘控制测试的有效性和可靠性。
背景:哮喘控制测试(ACT哮喘控制测试(ACT)已被广泛用于评估哮喘控制情况。然而,该测试从未在泰国成年哮喘患者中进行过验证:目的:确定泰文版 ACT 在泰国成年哮喘患者中的有效性和可靠性:采用斯皮尔曼等级相关系数确定 ACT 与哮喘控制水平之间的相关性。为了确定 ACT 的可靠性,在医生的两次就诊中(间隔 4-12 周)进行了 ACT 测验。使用接收者操作特征曲线下面积(AuROC)确定判别效度,以确定控制水平的最佳临界点:71名成年哮喘患者中有40名(56.3%)女性,平均年龄为(54.2 ± 14.7)岁。泰语版 ACT 的内部一致性信度为 Cronbach's alpha = 0.75,可以接受。测试-再测可靠性为 0.82。ACT 分数与 GINA 症状控制工具之间存在明显的相关性(r = 0.87,p < 0.001)。ACT得分≤22分可用于筛查 "未得到良好控制 "的哮喘,灵敏度为96.4%,特异度为93.0%;ACT得分≤19分可用于筛查 "未得到控制 "的哮喘:泰语版 ACT 是用于泰国成年哮喘患者的有效、可靠的工具。结论:泰语版 ACT 是用于泰国成年哮喘患者的有效、可靠的工具,但应将 ACT 控制水平的临界点分别改为 22 分和 19 分,以区分哮喘控制良好与部分控制、部分控制与未控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
12.80
自引率
0.00%
发文量
74
审稿时长
>12 weeks
期刊介绍: The Asian Pacific Journal of Allergy and Immunology (APJAI) is an online open access journal with the recent impact factor (2018) 1.747 APJAI published 4 times per annum (March, June, September, December). Four issues constitute one volume. APJAI publishes original research articles of basic science, clinical science and reviews on various aspects of allergy and immunology. This journal is an official journal of and published by the Allergy, Asthma and Immunology Association, Thailand. The scopes include mechanism, pathogenesis, host-pathogen interaction, host-environment interaction, allergic diseases, immune-mediated diseases, epidemiology, diagnosis, treatment and prevention, immunotherapy, and vaccine. All papers are published in English and are refereed to international standards.
期刊最新文献
Medication adherence, sensory attributes, and adverse effects of intranasal corticosteroids in allergic rhinitis patients: A systematic review and meta-analysis. A 10-year comparative study of factors for allergic asthma and/or rhinitis in two cross-sectional surveys. Binding specificity of HuScFv to cholangiocarcinoma cells; New avenues for diagnosis and treatment. Chimeric peptides targeting the receptor-binding domain of SARS-CoV-2 variants inhibit ACE2 interaction. Chronic rhinitis and its impact on COPD: A literature review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1